A novel molecular mechanism for stimulating uterine contractility by oxytocin
催产素刺激子宫收缩的新分子机制
基本信息
- 批准号:10703507
- 负责人:
- 金额:$ 51.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressCalciumCalcium ChannelCell SeparationCellsChargeClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDyesFetusFlow CytometryFrequenciesFundingFutureGoalsHumanImageIn VitroIon ChannelKnowledgeMeasuresMembraneMembrane PotentialsMolecularMusMyometrialOxytocinPathway interactionsPotassiumPotassium ChannelPregnancyPremature LaborProteinsProteomicsPublic HealthPublishingRegulationRelaxationReportingReproductive HealthRoleSignal TransductionSmooth MuscleSmooth Muscle MyocytesSodiumTestingTherapeuticTimeUterusWorkconditional knockouthuman tissueimprovedin vivoknock-downmRNA Expressionmembermyometriumnovelpatch clamppreventprotein expressionuterine contractilityvoltage sensitive dye
项目摘要
Project Summary
During pregnancy, the uterus gradually transitions from a quiescent state characterized by weak, asynchronous,
regional contractions to an activated state in which contractions increase in force, frequency, and synchrony to
expel the fetus at term. A major driver of this transition is gradual depolarization of the myometrial smooth muscle
cell (MSMC) membrane potential. As the inside of the membrane becomes less negatively charged, the
myometrium becomes more excitable. However, the molecular pathways controlling this transition are unknown,
hampering our ability to develop strategies to regulate uterine contractility to prevent pre- or post-term labor.
Here, we propose to test the central hypothesis that a sodium (Na+) signaling complex formed by the Na+-
activated potassium (K+) channel SLO2.1 and the Na+ leak channel NALCN regulates this transition. This
hypothesis is founded on published and preliminary data we obtained with funding from our previous R01. In
primary human MSMCs isolated at term, we showed that Na+ entry through NALCN activated K+ efflux through
SLO2.1 and hyperpolarized the membrane. Next, we showed that activation of this complex reduced tension in
uterine strips. Finally, we reported that inhibiting this complex induced MSMC depolarization, triggering calcium
(Ca2+) entry through voltage-dependent Ca2+ channels and promoting contractility. Together, these data indicate
that the NALCN/SLO2.1 complex is a strong candidate to control the MSMC membrane potential. However,
because we used human tissues, we could not determine the role of this complex in the gradual depolarization
of the MSMC membrane potential over pregnancy. To address this limitation and fully test our hypothesis, our
objective is to define the function and regulation of the NALCN/SLO2.1 complex across pregnancy in mouse
MSMCs. The goals of this project are to: 1) Define NALCN/SLO2.1 complex activity across pregnancy, 2) Assess
the effects of NALCN/SLO2.1 complex activity on intracellular Ca2+ and uterine contractility and 3) Identify
additional members of the NALCN/SLO2.1 complex in MSMCs and determine their effects on functionality of the
complex. In completing these aims, we will define the main regulators of MSMC membrane potential and how
they change as pregnancy progresses. This work will facilitate future efforts aimed at developing therapeutics to
inhibit the NALCN/SLO2.1 complex to promote labor or to activate the complex to promote quiescence and
prevent preterm labor.
项目摘要
在怀孕期间,子宫逐渐从静止状态过渡,其特征是虚弱,异步,
局部收缩到激活状态,其中收缩的力度、频率和同步性增加,
在足月时排出胎儿这种转变的主要驱动力是子宫肌层平滑肌的逐渐去极化
细胞(MSMC)膜电位。随着膜内部的负电荷减少,
子宫肌层变得更加兴奋。然而,控制这种转变的分子途径是未知的,
阻碍了我们制定策略来调节子宫收缩力以防止早产或足月分娩的能力。
在这里,我们建议测试中心假设,钠(Na+)信号复合物形成的Na+-
激活的钾(K+)通道SLO 2.1和Na+泄漏通道NALCN调节该转换。这
假设是建立在我们从以前的R 01获得的资助的已发表和初步数据上的。在
在足月时分离的原代人MSMCs中,我们发现Na+通过NALCN进入激活K+通过
SLO 2.1和超极化膜。接下来,我们证明了这种复合物的激活降低了细胞内的张力。
子宫条最后,我们报道了抑制这种复合物诱导MSMC去极化,触发钙离子通道,
(Ca2+)通过电压依赖性Ca 2+通道进入并促进收缩性。这些数据表明,
NALCN/SLO 2.1复合物是控制MSMC膜电位的强有力的候选者。然而,在这方面,
因为我们使用的是人体组织,我们不能确定这种复合物在逐渐去极化中的作用。
MSMC膜电位的变化。为了解决这一局限性并充分验证我们的假设,我们
目的探讨NALCN/SLO 2.1复合物在小鼠妊娠过程中的功能和调控
MSMCs。该项目的目标是:1)定义整个妊娠期间NALCN/SLO 2.1复合物的活性,2)评估
NALCN/SLO 2.1复合物活性对细胞内Ca 2+和子宫收缩力的影响;
另外的成员NALCN/SLO2.1复合物中的MSMCs,并确定其对功能的影响,
复杂.在完成这些目标,我们将确定的主要调节MSMC膜电位和如何
它们会随着怀孕的进展而改变这项工作将促进未来旨在开发治疗方法的努力,
抑制NALCN/SLO 2.1复合物以促进分娩或激活复合物以促进静止,
预防早产。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SLO2.1/NALCN a sodium signaling complex that regulates uterine activity.
- DOI:10.1016/j.isci.2021.103210
- 发表时间:2021-11-19
- 期刊:
- 影响因子:5.8
- 作者:Ferreira JJ;Amazu C;Puga-Molina LC;Ma X;England SK;Santi CM
- 通讯作者:Santi CM
Na+-Leak Channel, Non-Selective (NALCN) Regulates Myometrial Excitability and Facilitates Successful Parturition.
- DOI:10.1159/000491805
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah K. England其他文献
Diet Quality in Pregnancy and the Risk of Fetal Growth Restriction
- DOI:
10.1016/j.ajog.2021.11.081 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:
- 作者:
Xiao Yu Wang;Peinan Zhao;Antonina I. Frolova;Anthony O. Odibo;Ebony B. Carter;Jeannie C. Kelly;Sarah K. England;Nandini Raghuraman - 通讯作者:
Nandini Raghuraman
The association between first trimester physical activity levels and perinatal outcomes
孕早期身体活动水平与围产期结局之间的关联
- DOI:
10.1016/j.ajogmf.2024.101534 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:3.100
- 作者:
Virginia Y. Watkins;Peinan Zhao;Antonina I. Frolova;Ebony B. Carter;Jeannie C. Kelly;Anthony O. Odibo;Sarah K. England;Nandini Raghuraman - 通讯作者:
Nandini Raghuraman
800: Area deprivation index and adverse obstetric outcomes
- DOI:
10.1016/j.ajog.2019.11.815 - 发表时间:
2020-01-01 - 期刊:
- 影响因子:
- 作者:
Molly J. Stout;Megan C. Oakes;Jessica Chubiz;Olivia Passafiume;Anjana Delhi;Candice Woolfolk;Emily Jungheim;Sarah K. England;George A. Macones;Methodius G. Tuuli - 通讯作者:
Methodius G. Tuuli
Sleep variability and time to achieving pregnancy: findings from a pilot cohort study of women desiring pregnancy
睡眠变异性与受孕时间:一项针对渴望怀孕女性的试点队列研究结果
- DOI:
10.1016/j.fertnstert.2025.01.019 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:7.000
- 作者:
Peinan Zhao;Emily S. Jungheim;Bronwyn S. Bedrick;Leping Wan;Patricia T. Jimenez;Ronald McCarthy;Jessica Chubiz;Justin C. Fay;Erik D. Herzog;Siobhan Sutcliffe;Sarah K. England - 通讯作者:
Sarah K. England
1125: First trimester stress and depression as risk factors for preterm birth
- DOI:
10.1016/j.ajog.2019.11.1137 - 发表时间:
2020-01-01 - 期刊:
- 影响因子:
- 作者:
Megan C. Oakes;Jessica Chubiz;Olivia Passafiume;Bronwyn Bedrick;Sarah K. England;George A. Macones;Methodius G. Tuuli;Emily Jungheim;Molly J. Stout - 通讯作者:
Molly J. Stout
Sarah K. England的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah K. England', 18)}}的其他基金
Quantitative and computational characterization of oxytocin receptor signaling
催产素受体信号传导的定量和计算表征
- 批准号:
10428510 - 财政年份:2019
- 资助金额:
$ 51.74万 - 项目类别:
Quantitative and computational characterization of oxytocin receptor signaling
催产素受体信号传导的定量和计算表征
- 批准号:
10206215 - 财政年份:2019
- 资助金额:
$ 51.74万 - 项目类别:
Quantitative and computational characterization of oxytocin receptor signaling: Administrative supplement
催产素受体信号传导的定量和计算表征:行政补充
- 批准号:
10175765 - 财政年份:2019
- 资助金额:
$ 51.74万 - 项目类别:
Quantitative and computational characterization of oxytocin receptor signaling
催产素受体信号传导的定量和计算表征
- 批准号:
10636923 - 财政年份:2019
- 资助金额:
$ 51.74万 - 项目类别:
A novel molecular mechanism for stimulating uterine contractility by oxytocin
催产素刺激子宫收缩的新分子机制
- 批准号:
10539176 - 财政年份:2016
- 资助金额:
$ 51.74万 - 项目类别:
A NOVEL MOLECULAR MECHANISM FOR STIMULATING UTERINE CONTRACTILITY BY OXYTOCIN
催产素刺激子宫收缩的新型分子机制
- 批准号:
9251837 - 财政年份:2016
- 资助金额:
$ 51.74万 - 项目类别:
THE ROLE OF THE BKCA CHANNEL IN THE REGULATION OF UTERINE EXCITABILITY
BKCA 通道在子宫兴奋性调节中的作用
- 批准号:
7604805 - 财政年份:2007
- 资助金额:
$ 51.74万 - 项目类别:
THE ROLE OF THE BKCA CHANNEL IN THE REGULATION OF UTERINE EXCITABILITY
BKCA 通道在子宫兴奋性调节中的作用
- 批准号:
7376987 - 财政年份:2006
- 资助金额:
$ 51.74万 - 项目类别:
相似国自然基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
- 批准号:81670699
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
- 批准号:30900771
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 51.74万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 51.74万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 51.74万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 51.74万 - 项目类别: